Commercial insight into the pharma and biotech sector.

Solutions for Investor Relations

To effectively communicate your company’s profile to the investment community you need to understand how investors perceive your company’s assets and performance versus its peers. EvaluatePharma puts the latest product and company data into market context, benchmarking your company’s performance, its products and its valuation so you can anticipate investor sentiment and react accordingly.

  • Monitor and respond to changes in market expectations for your company & your peers down to product level
  • Stay ahead of key events across the industry & anticipate those that will impact share price with the Calendar of Events
  • Model potential impact of news-breaking events on your company’s share price with our interactive NPV Analyzer including clinical trials, product approvals, patent extension & litigation
  • Evaluate the impact of merger scenarios with unique Merge tool & create virtual companies in a few clicks to react quickly to market speculation and M&A announcements
  • Produce industry analysis for investor presentations in an instant with our powerful editing tool

Find out more Download Solutions for Investor Relations

Register for access to a selection of free analysis and insights 


Exclusive Analysis & Insights

Global Market Analytics             Financial Information
Product Forecasts to 2016        Sales by Indication
Partnering Opportunities   Archived Sales Forecasts
Drug Information                         R&D Pipeline
Clinical Trials                     Venture Financing

Exclusive Analysis & Insights

Licensing Deals                               M&A Activity 
Patent Risk                                       NPV Analyzer
EP Vantage & EventAnalyzer          Calendar of Events
NewsManager                                 Peer Group Analyzer
Merge Company & Company Rank